OncoSec announced the receipt of $3.49M in tax credit certificates from the New Jersey Economic Development Authority – NJEDA -. The tax credit certificates are offered to qualified companies through the NJEDA’s Technology Business Tax Certificate Transfer Program, which enables eligible technology and biotechnology companies based in New Jersey to sell unused net operating losses and research and development tax credits for cash proceeds.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ONCS:
